�鶹��madou

Dr. Abu Sina is a Senior Lecturer and Group Leader of Sina Lab at the School of Biotechnology and Biomolecular Sciences, �鶹��madou Sydney. Prior to this role, he served as a Senior Research Fellow at the Center for Personalized Nanomedicine and a Theme Leader at the Center for Materials Space-Tectonics (CeMaSTec), both part of the Australian Institute for Bioengineering & Nanotechnology (AIBN) at The University of Queensland (UQ), Australia. His career also includes international research appointments as a Visiting Scientist at the Dana-Farber Cancer Institute, Harvard University, and a Visiting Research Fellow at the Irving Cancer Research Center, Columbia University, NY, USA, where he spent two years collaborating with leading experts in oncology and systems biology.

At UQ, Dr. Sina worked alongside ARC Laureate Fellow and Former Federation Fellow, Professor Matt Trau, contributing to groundbreaking research in nanomedicine. During his time at Harvard, he collaborated with Professor Adam Bass, now the Global Head of Oncology Translational Research at Novartis. His tenure at Columbia University included work with Professor Andrea Califano, currently the President of the $270M Chan-Zuckerberg Biohub in New York and a Professor in the Systems Biology Department at Columbia University.

Dr. Sina earned his PhD in Biomedical Engineering in 2017 from The University of Queensland, Australia, following his Bachelor with Honours and Master's in Chemistry from Shahjalal University of Science & Technology, Bangladesh. His diverse academic and research journey reflects a commitment to advancing translational nanomedicine and molecular diagnostics on a global scale.